Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells

European Journal of Pharmacology

Volumn 606, Issue 1-3, 2009, Pages 25-31

  Hendriks Balk, Mariëlle C ^a   Hajji, Najat ^a   van Loenen, Pieter B ^a   Michel, Martin C ^a   Peters, Stephan L M ^a   Alewijnse, Astrid E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

FTY720 P; Regulator of G protein signalling; Sphingosine 1 phosphate receptor; VSMC

Indexed keywords

MESSENGER RNA; RGS 16 PROTEIN; RGS PROTEIN; RGS2 PROTEIN; RGS4 PROTEIN; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RGS16 GENE; RGS2 GENE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; GENE EXPRESSION REGULATION; LYSOPHOSPHOLIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RECEPTORS, LYSOSPHINGOLIPID; RGS PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOSINE; UP-REGULATION;

EID: 60949089944     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.018     Document Type: Article

References (40)

1. Albert R., Hinterding K., Brinkmann V., Guerini D., Muller-Hartwieg C., Knecht H., Simeon C., Streiff M., Wagner T., Welzenbach K., Zecri F., Zollinger M., Cooke N., and Francotte E. Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer. J. Med. Chem. 48 (2005) 5373-5377
2. Alewijnse A.E., and Peters S.L. Sphingolipid signalling in the cardiovascular system: good, bad or both?. Eur. J. Pharmacol. 585 (2008) 292-302
3. Alewijnse A.E., Jongsma M., Mathy M.-J., van Loenen P.B., Hajji N., Michel M.C., and Peters S.L. Characterization of the vasoactive properties of S1P receptors in rat aorta. FASEB J. 22 (2008) 912.914 (Abstract)
4. Calo L.A., Pagnin E., Davis P.A., Sartori M., Ceolotto G., Pessina A.C., and Semplicini A. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J. Clin. Endocrinol. Metab. 89 (2004) 4153-4157
5. Calo L.A., Pagnin E., Ceolotto G., Davis P.A., Schiavo S., Papparella I., Semplicini A., and Pessina A.C. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. J. Hypertens. 26 (2008) 938-945
6. Cho H., Harrison K., Schwartz O., and Kehrl J.H. The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine-1-phosphate, angiotensin II and endothelin-1 signalling. Biochem. J. 371 (2003) 973-980
7. Cho H., Park C., Hwang I.Y., Han S.B., Schimel D., Despres D., and Kehrl J.H. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol. Cell. Biol. 28 (2008) 2590-2597
8. Demoliou-Mason C.D. G-protein-coupled receptors in vascular smooth muscle cells. Biol. Signals Recept. 7 (1998) 90-97
9. Grant S.L., Lassegue B., Griendling K.K., Ushio-Fukai M., Lyons P.R., and Alexander R.W. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol. Pharmacol. 57 (2000) 460-467
10. Grayson T.H., Ohms S.J., Brackenbury T.D., Meaney K.R., Peng K., Pittelkow Y.E., Wilson S.R., Sandow S.L., and Hill C.E. Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets. BMC Genomics 8 (2007) 404
11. Hendriks-Balk M.C., Michel M.C., and Alewijnse A.E. Pitfalls in the normalization of real-time polymerase chain reaction data. Basic Res. Cardiol. 102 (2007) 195-197
12. Hendriks-Balk M.C., Peters S.L., Michel M.C., and Alewijnse A.E. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur. J. Pharmacol. 585 (2008) 278-291
13. Hendriks-Balk M.C., van Loenen P.B., Hajji N., Michel M.C., Peters S.L., and Alewijnse A.E. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells. Eur. J. Pharmacol. 600 (2008) 1-9
14. Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., Oliveira-dos-Santos A., Penninger J.M., Muslin A.J., Steinberg T.H., Wyss J.M., Mecham R.P., and Blumer K.J. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111 (2003) 445-452
15. Hollinger S., and Hepler J.R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54 (2002) 527-559
16. Inoue S., Nakazawa T., Cho A., Dastvan F., Shilling D., Daum G., and Reidy M. Regulation of arterial lesions in mice depends on differential smooth muscle cell migration: a role for sphingosine-1-phosphate receptors. J. Vasc. Surg. 46 (2007) 756-763
17. Kohno T., and Igarashi Y. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. Genes Cells 13 (2008) 747-757
18. Li Y., Hashim S., and Anand-Srivastava M.B. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells. Cardiovasc. Res. 66 (2005) 503-511
19. Michel M.C., Mulders A.C., Jongsma M., Alewijnse A.E., and Peters S.L. Vascular effects of sphingolipids. Acta Paediatr. Suppl. 96 (2007) 44-48
20. Okamoto H., Takuwa N., Yokomizo T., Sugimoto N., Sakurada S., Shigematsu H., and Takuwa Y. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol. Cell. Biol. 20 (2000) 9247-9261
21. Peters S.L., and Alewijnse A.E. Sphingosine-1-phosphate signaling in the cardiovascular system. Curr. Opin. Pharmacol. 7 (2007) 186-192
22. Riddle E.L., Schwartzman R.A., Bond M., and Insel P.A. Multi-tasking RGS proteins in the heart: the next therapeutic target?. Circ. Res. 96 (2005) 401-411
23. Ross E.M., and Wilkie T.M. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69 (2000) 795-827
24. Semplicini A., Lenzini L., Sartori M., Papparella I., Calo L.A., Pagnin E., Strapazzon G., Benna C., Costa R., Avogaro A., Ceolotto G., and Pessina A.C. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J. Hypertens. 24 (2006) 1115-1124
25. Sensken S.C., Staubert C., Keul P., Levkau B., Schoneberg T., and Graler M.H. Selective activation of G alpha i mediated signalling of S1P(3) by FTY720-phosphate. Cell. Signal. 20 (2008) 1125-1133
26. Siderovski D.P., and Willard F.S. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int. J. Biol. Sci. 1 (2005) 51-66
27. Stuebe S., Wieland T., Kraemer E., Stritzky A., Schroeder D., Seekamp S., Vogt A., Chen C.K., and Patten M. Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene. Naunyn Schmiedebergs Arch. Pharmacol. 376 (2008) 363-373
28. Sun X., Kaltenbronn K.M., Steinberg T.H., and Blumer K.J. RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol. Pharmacol. 67 (2005) 631-639
29. Tamama K., and Okajima F. Sphingosine-1-phosphate signaling in atherosclerosis and vascular biology. Curr. Opin. Lipidol. 13 (2002) 489-495
30. Tang K.M., Wang G.R., Lu P., Karas R.H., Aronovitz M., Heximer S.P., Kaltenbronn K.M., Blumer K.J., Siderovski D.P., Zhu Y., and Mendelsohn M.E. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9 (2003) 1506-1512
31. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 90 (2005) 449-455
32. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
33. Wamhoff B.R., Lynch K.R., Macdonald T.L., and Owens G.K. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1454-1461
34. Wang X., Adams L.D., Pabon L.M., Mahoney Jr. W.M., Beaudry D., Gunaje J., Geary R.L., Deblois D., and Schwartz S.M. RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy. J. Mol. Cell. Cardiol. 44 (2008) 539-550
35. Wieland T., and Mittmann C. Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol. Ther. 97 (2003) 95-115
36. Xie G.X., and Palmer P.P. How regulators of G protein signaling achieve selective regulation. J. Mol. Biol. 366 (2007) 349-365
37. Xie Z., Li Z., Guo L., Ye C., Li J., Yu X., Yang H., Wang Y., Chen C., Zhang D., and Liu-Chen L.Y. Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptors. Eur. J. Pharmacol. 565 (2007) 45-53
38. Yang J., Kamide K., Kokubo Y., Takiuchi S., Tanaka C., Banno M., Miwa Y., Yoshii M., Horio T., Okayama A., Tomoike H., Kawano Y., and Miyata T. Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J. Hypertens. 23 (2005) 1497-1505
39. Zhang W., Anger T., Su J., Hao J., Xu X., Zhu M., Gach A., Cui L., Liao R., and Mende U. Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J. Biol. Chem. 281 (2006) 5811-5820
40. Zou M.X., Roy A.A., Zhao Q., Kirshenbaum L.A., Karmazyn M., and Chidiac P. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes. Cell. Signal. 18 (2006) 1655-1663